Saraban, Alma I.
HRN: 21-89-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
MEBENDAZOLE 500MG (TAB)
11/19/2022
11/19/2022
PO
500mg
Single Dose
Parasitism
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes